-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Initiates Coverage On Neurogene with Overweight Rating, Announces Price Target of $60

Benzinga·10/08/2026 13:58:03
JP Morgan analyst Priyanka Grover initiates coverage on Neurogene (NASDAQ:NGNE) with a Overweight rating and announces Price Target of $60.